Pharmacokinetics of benzene

Area of Science:

• Toxicology
• Pharmacokinetics
• Computational Biology

Background:

• Benzene is a common environmental pollutant with known toxicity.
• Understanding benzene's absorption, distribution, metabolism, and excretion (ADME) is crucial for risk assessment.
• Previous models may not fully capture species-specific and route-dependent pharmacokinetics.

Purpose of the Study:

• To develop and validate a physiologically based pharmacokinetic (PBPK) model for benzene.
• To describe benzene pharmacokinetics in mice, rats, and humans.
• To evaluate the model's performance across multiple exposure routes.

Main Methods:

• A PBPK model was constructed, dividing the body into five compartments: liver, fat, bone marrow, muscle, and other organs.
• Benzene metabolism was modeled using Michaelis-Menten (nonlinear) kinetics, primarily in the liver and bone marrow.
• The model was calibrated and validated using empirical data from inhalation, gavage, and injection studies.

Main Results:

• The PBPK model successfully described benzene pharmacokinetics in mice, rats, and humans.
• Model predictions aligned well with experimental data across different administration routes.
• Nonlinear metabolism of benzene was consistently observed in all species.

Conclusions:

• Physiologically based pharmacokinetic modeling is a valuable tool for understanding benzene pharmacokinetics.
• The developed model provides a robust framework for predicting benzene behavior in vivo.
• This approach can inform benzene risk assessment and management strategies.